An example is Fc-fusion to the tumor necrosis factor (TNF) receptor (Etanercept, Enbrel®), which blocks binding of TNF-α to cellular TNF receptor and thus inhibits pro-inflammatory activity in rheumatoid arthritis patients (207). Here, TNF is linked to rheumatoid arthritis.